SCHEMBL6861568

SCHEMBL6861568

C[SiH](C)OC([C@H]1C[C@@H](c2ccc(OCc3ccccc3)cc2)C(=O)N1C(=O)OC(C)(C)C)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
YAP1 P46937 3/20 0.41
MMP13 P45452 1/20 0.39
GHSR Q92847 4/20 0.38
KDM1A O60341 2/20 0.38
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
MCL1 Q07820 1/20 0.38
PRMT5 O14744 1/20 0.37
TP53 P04637 1/20 0.37
LTA4H P09960 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
NR4A1 P22736 1/20 0.36
NR4A2 P43354 1/20 0.36
NR4A3 Q92570 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6866096 0.80 MMP13 (0.44) YAP1MMP13GHSRKDM1AMAOA
SCHEMBL6861263 0.78 YAP1 (0.40) YAP1MMP13GHSRMCL1PRMT5
SCHEMBL6861570 0.74 YAP1 (0.40) YAP1MMP13GHSRMCL1PRMT5
SCHEMBL8229952 0.74 YAP1 (0.40) YAP1MMP13GHSRMCL1PRMT5
SCHEMBL353103 0.72 KLK7 (0.43)
SCHEMBL13701096 0.71 YAP1 (0.47) YAP1GHSRMAOBPRMT5TP53
SCHEMBL13701098 0.71 YAP1 (0.44) YAP1MMP13GHSRMAOAMAOB
SCHEMBL13701121 0.71 YAP1 (0.43) YAP1MMP13GHSRPRMT5TP53
SCHEMBL21877176 0.69 YAP1 (0.52) YAP1MAOBPRMT5LTA4H
SCHEMBL22546600 0.69 MAOB (0.44) YAP1GHSRMAOBPRMT5NR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1004578-B1 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives PFIZER PROD INC (US) 2004-02-25 EP disclosed
US-6114361-A INHIBITORS OF MATRIX METALLOPROTEINASES AND REPROLYSIN; ADMINISTERING TO TREAT CONDITIONS WHICH CAN BE TREATED BY THE INHIBITION OF THESE ENZYMES PFIZER INC. (US) 2000-09-05 US disclosed
EP-1004578-A2 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives Pfizer Products Inc. (US) 2000-05-31 EP disclosed